Medipost Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipost Co Ltd with three other
companies in this sector in South Korea:
sales of 28.45 billion Korean Won [US$25.21 million]
(23.81 billion Korean Won [US$21.10 million]
of which 58%
was Biotechnology), and
Seoulin Bioscience Company Limited
(42.62 billion Korean Won [US$37.76 million]
Medipost Co Ltd reported sales of 42.25 billion Korean Won (US$37.43 million)
December of 2017.
increase of 47.4%
versus 2016, when the company's sales were 28.65 billion Korean Won.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Medipost Co Ltd had sales
of 40.77 billion Korean Won.
Sales of Other Segment saw an increase
that was more than double the company's growth rate: sales were up
137.5% in 2017, from
2.88 billion Korean Won to 6.84 billion Korean Won.
Medipost Co Ltd also saw significant increases in sales in
Therapy Sales (up 77.9% to 10.03 billion Korean Won)